home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Gene Therapy Alleviates Neurodegenerative Disease In Mice

 
  March, 20 2008 8:54
your information resource in human molecular genetics
 
     

Mice with neurodegenerative diseases have been successfully treated with gene therapy, according to research published online in EMBO reports. Using lentivirus vectors, scientists were able to administer a therapeutic enzyme to treat spinocerebellar ataxia, a neurodegenerative disease that currently has no cure.

Mutations in the DNA sequence of several genes cause the proteins they encode to contain abnormally large amounts of the amino acid glutamine. Over time, the build up of polyglutamine aggregates leads to neurological degeneration and the onset of disease symptoms. Hirokazu Hirai and co-workers artificially overexpressed CRAG - the enzyme that naturally assists in breaking down the polyglutamine aggregates - in the affected mice, which where then able to clear the aggregates. Subsequently, neurons were rescued from degeneration and the disease symptoms markedly alleviated.

Polyglutamine diseases, such as spinocerebellar ataxia or Huntington's disease, are not fatal, but the symptoms and complications they cause result in a very poor quality of life and a reduced life expectancy for those affected. The team hopes that their work in mice can be developed into a clinical treatment for the nine types of polyglutamine disease that result from these kinds of genetic errors.

Author contact:

Hirokazu Hirai (Gunma University Graduate School of Medicine, Japan)
Email: hiraih@med.gunma-u.ac.jp

(C) EMBO press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.